Elekta

http://www.elekta.com

Elekta AB, Stockholm , Sweden.

Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders
Elekta AB - Company Profile

Elekta Demonstrates Continued Leadership in Image Guidance at 2009 ASTRO Annual Meeting

Wednesday 28th of October 2009 9:00

    --  In celebrating the production of their 2,000th digital linear
        accelerator, Elekta will unveil a sixth-generation digital treatment
        control system, Integrity(TM)**. Taking advantage of a complete
        re-engineering into the LynX OS platform, Integrity adds to its
        reputation for efficiency and reliability; MLC interdigitation,
        continuously variable dose rate for VMAT and enhanced virus protection.

    --  Elekta Infinity, a premier digital linear accelerator optimized for
        Volumetric Modulated Arc Therapy (VMAT). With its unique multi-arcing
        capabilities, Infinity delivers unmatched dose conformance, treatment
        speed and ultra-low dose safeguards and is the only fully integrated
        treatment system that allows personalization of imaging and treatment
        workflows.

    --  MOSAIQ® 2.0 , a comprehensive oncology charting solution that increases
        productivity, elevates efficiency and facilitates high-quality patient
        care. Complete with new connectivity, new functions and database
        enhancements, while preserving the user interface, MOSAIQ supports the
        entire cancer team by uniting diverse systems and devices.

    --  Monaco® with VMAT, a next generation IMRT treatment planning system
        that helps make the planning process easier, more straightforward and
        clinically reliable. With reduced planning time and increased clinical
        throughput, Monaco with VMAT optimizes single or multiple non-coplanar
        arcs simultaneously, providing the flexibility and control needed for
        complex treatment plans.

    --  Extend(TM), a new stereotactic treatment program that lets neurosurgeons
        and radiation oncologists apply the power and precision of Gamma Knife®
        surgery to a broader class of targets in the head and neck. Now
        available in the United States, Extend for Leksell Gamma Knife®
        Perfexion(TM) includes a re-locatable frame and support for fractionated
        treatments, which provides cross functional advantages in SRS and SRT
        for neurosurgeons and radiation oncologists.

A complete product preview also will be provided to Elekta, Impac and CMS customers Saturday, October 31 at the Radiation Oncology Users Meeting (ROUM). Now in its 18th year, the ROUM will cover topics such as the latest technology and treatment techniques for cancer care, government stimulus and changes in reimbursement.

"Everyone attending ASTRO and the ROUM will recognize how the Elekta Group, including Impac and CMS Software, has moved forward with a shared vision to deliver advances that help patients live longer, better lives," says Jay Hoey, President and CEO of Elekta North America. "In addition, customers will see how this shared vision is evolving into intelligent solutions they can easily integrate into their clinics."

Events held in conjunction with ASTRO

In addition to the Users Meeting, Elekta plans to host the following events:

    --  Daily clinical presentations, Sunday, November 1 - Tuesday, November 3
        at Elekta booth 2501. For a complete speaker schedule, visit
        www.elekta.com/astro_presentations

    --  Halloween Charity Bash, Saturday, October 31 from 7:30 - 11:30 p.m. at
        Union Station Chicago, 225 South Canal Street. For additional
        information, visit www.elekta.com/astroevents

    --  Investor Meeting, Tuesday, November 2 from noon - 2 p.m. at the Hilton
        Hotel, Marquette Room, 720 South Michigan Avenue

*Intuity and Symmetry are feature sets of XVI 4.5, works in progress requiring a 510(k) review and not yet available in the U.S.

**Integrity is a works in progress requiring 510(k) review and not yet available in the U.S.

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.

SOURCE Elekta

Source PR Newswire


www.prnewswire.co.uk

Browse news from 2009

Download PDF